Skip to main content

Advertisement

Fig. 11 | Biology Direct

Fig. 11

From: Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data

Fig. 11

Fitting the model to breast cancer data. Graphical representation of the fitting results of the vascular tumour growth and response to bevacizumab treatment model to experimental data concerning KPL-4 human estrogen receptor-negative breast adenocarcinoma xenografts that were extracted from [60]: a In the context of a bevacizumab monotherapy study, b In the context of a bevacizumab combination treatment study

Back to article page